Stay updated on HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial
Sign up to get notified when there's something new on the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page.

Latest updates to the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a Locations section with California as the site and removed the California Locations entry. Updated revision metadata to v3.3.3 and removed the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1 on the page, representing a small version update with no impact on the study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.1 on the page header; no study content, eligibility criteria, or outcomes were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedRemoved the site-wide government funding/operating-status notice from the page, and core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedNo significant content changes were detected; any observed differences appear to be minor formatting or UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the old version (v3.0.2).SummaryDifference3%

Stay in the know with updates to HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page.